Complementary and alternative medicine for advanced prostate cancer (Q36456507)

14 August 2017

title

Complementary and alternative medicine for advanced prostate cancer (English)

1 reference

14 August 2017

1 reference

J Daniell Rackley

1

1 reference

14 August 2017

Peter E Clark

series ordinal

2

1 reference

14 August 2017

M Craig Hall

series ordinal

3

1 reference

14 August 2017

publication date

1 May 2006

1 reference

Urologic Clinics of North America

14 August 2017

published in

1 reference

14 August 2017

volume

33

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

237-46, viii

1 reference

14 August 2017

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Epidemiologic determinants of clinically relevant prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Supplement use among men with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Lycopene Uptake and Tissue Disposition in Male and Female Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Intake of carotenoids and retinol in relation to risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Lycopene as the most efficient biological carotenoid singlet oxygen quencher

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Deficient nucleotide excision repair capacity enhances human prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Carotenoids affect proliferation of human prostate cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Carotenoids and gene regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Lycopene oxidation product enhances gap junctional communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Nutrition and prostate cancer: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Cell Cycle Arrest and Induction of Apoptosis by Lycopene in LNCaP Human Prostate Cancer Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Protective effects of silymarin against photocarcinogenesis in a mouse skin model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Shark cartilage for cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Toward therapeutic intervention of cancer by vitamin D compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Induction of apoptosis by vitamin D3 analogue EB1089 in NCI-H929 myeloma cells via activation of caspase 3 and p38 MAP kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Vitamin d inhibition of prostate adenocarcinoma growth and metastasis in the dunning rat prostate model system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Green tea consumption enhances survival of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Green-tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Phase I trial of oral green tea extract in adult patients with solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Molecular targets for green tea in prostate cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

An analysis of cancer prevention by selenium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Inhibitory effects of selenium on the growth of DU-145 human prostate carcinoma cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Selenium and vitamin E cancer prevention trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Genistein-induced upregulation of p21WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Soy intake and cancer risk: a review of the in vitro and in vivo data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Steroid hormone activity of flavonoids and related compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Effects of a genistein-rich extract on PSA levels in men with a history of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

PC-SPES: a unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo .

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Herbal composition PC-SPES for management of prostate cancer: identification of active principles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2005.12.007

10.1016/J.UCL.2005.12.007

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference